Nektar Therapeutics NKTR
NASDAQ NKTR
$60.54 +1.30 (+2.20%)
At close: Sep 30, 2026 · 4:00 PM EDT

Nektar Therapeutics (NKTR) Convertible Debt (2010 - 2011)

Updated

Nektar Therapeutics (NKTR) recorded Convertible Debt of $214.96 million in Q4 2011, unchanged from $214.96 million a year earlier.

Analysis

Nektar Therapeutics (NKTR) Convertible Debt (2010 - 2011) Analysis & Trends

Starting with Q4 2010, Nektar Therapeutics' Convertible Debt history includes 4 quarters.

  • Across earlier years, Convertible Debt came in at $214.96 million in FY2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Nektar Therapeutics 1.96 Bn 189.27 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2011 214.96 Mn
Jun 30, 2011 214.96 Mn
Mar 31, 2011 214.96 Mn
Dec 31, 2010 214.96 Mn
API Access

Nektar Therapeutics Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=NKTR&period=max&api_key=YOUR_API_KEY